The study found that participants with Type 2 diabetes who were prescribed semaglutide were 4.28 times more likely to develop NAION
if you become pregnant whilst on treatment, stop the medication and seek immediate medical and nutritional review [1] [25] Contact your GP urgently if you experience: Severe, persistent abdominal pain (with or without vomiting) which could indicate pancreatitis Upper-right abdominal pain, fever or jaundice which may suggest gallbladder disease Persistent nausea or vomiting preventing adequate nutrition Signs of dehydration (dark urine, dizziness, reduced urination) Unexplained symptoms such as jaundice, severe fatigue, or mood changes For people with diabetes: hypoglycaemia (low blood sugar) symptoms when taking insulin or sulfonylureas alongside GLP-1 therapy Regular monitoring throughout GLP-1 treatment should include periodic assessment of weight, body composition where possible, nutritional intake, and relevant blood markers
Most people report noticing changes in hair strength, shine, or thickness after 3 to 6 months of consistent daily use
What is the current scientific data on the safety of GLP-1 agonists and SGLT2 inhibitors during pregnancy and/or lactation
